Cardiff Oncology (CRDF) Net Margin Growth (5y) (2016 - 2026)
Cardiff Oncology (CRDF) Net Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106,290.00 |
| Dec 31, 2025 | 257,631.00 |
| Sep 30, 2025 | -607,564.00 |
| Jun 30, 2025 | 567,423.00 |
| Mar 31, 2025 | -630,822.00 |
| Dec 31, 2024 | -329,361.00 |
| Sep 30, 2024 | 83,599.00 |
| Jun 30, 2024 | 398,124.00 |
| Mar 31, 2024 | 185,186.00 |
| Dec 31, 2023 | -65,098.00 |
| Sep 30, 2023 | -263,272.00 |
| Jun 30, 2023 | -449,619.00 |
| Mar 31, 2023 | -375,981.00 |
| Dec 31, 2022 | -540,679.00 |
| Sep 30, 2022 | -191,040.00 |
| Jun 30, 2022 | -358,928.00 |
| Mar 31, 2022 | 33,655.00 |
| Dec 31, 2021 | 547,565.00 |
| Sep 30, 2021 | 341,195.00 |
| Jun 30, 2021 | -13,020.00 |